{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":""},{"Key":"CEHoursPP8","Value":""},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":""},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"1"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":"","ContentCaptureVendorSpecification":null,"Created":null,"Date":"2022-04-12","Description":"<p>Please join Daiichi-Sankyo, Inc. and AstraZeneca, on Tuesday, April 12th, 2022 at 12:30 PM in Theater D for an informative, expert-led discussion by Kit Y. Lu, MD to explore the advancements in the treatment of HER2+ unresectable or metastatic breast cancer. To learn more visit: <a href=\"https:\/\/nam04.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fwww.her2mbctreatmenthcp.com%2F&amp;data=04%7C01%7Cexhibits%40aacr.org%7Ced3701e89d0048571cfd08d9fdefc48a%7C246e714fe4c240eba104f70e9c80d6dc%7C1%7C0%7C637820028530700139%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=oaG6CxUErnr41edehJ4bgvdqEH5JH6ze5Z3hH%2Fobzis%3D&amp;reserved=0\">www.her2mbctreatmenthcp.com<\/a><\/p>\u000a","Duration":60,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/12\/2022 1:30:00 PM","EndTime":"13:30","HidePresentationRating":"False","HidePresentations":"False","Id":"830","Key":"09b7a1d2-22a5-4149-a3a2-87a41f2b13d8","LastUpdated":"2022-03-25 12:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"Spotlight Theater D, Halls D-H","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"ESP24","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Incomplete","SearchResultBody":"ESP24. Daiichi Sankyo, Inc.: Exploring the Advancements in the Treatment of HER2+ Unresectable or Metastatic Breast Cancer","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"Spotlight Theater D, Halls D-H","SearchResultHeader":"Apr 12 2022 12:30PM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/12\/2022 12:30:00 PM","StartTime":"12:30","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Daiichi Sankyo, Inc.: Exploring the Advancements in the Treatment of HER2+ Unresectable or Metastatic Breast Cancer","Type":null,"TypeKey":null}